Platform presentation highlights open-label, long-term safety and tolerability results, durability of effect over time in both EDS and cataplexy in patients with narcolepsy Harmony Biosciences, LLC (Harmony) recently presented new data on pitolisant at the 7th International Symposium on Narcolepsy in Beverly, MA. Pitolisant is an investigational product that has […]
Clinical Insights & Research
Sunovion First To Offer Nebulized Long-Acting Muscarinic Antagonist (LAMA) For COPD In The U.S.
Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily) is now available at pharmacies in the U.S. for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. LONHALA MAGNAIR is the first […]
Could Cannabis Be The Answer To Some Sleep Disorders?
Millions of people who suffer from some form of insomnia. Whether it be brief symptoms or chronic, not getting the recommended amount of sleep is something that can affect everyday life. Lack of sleep can cause lower productivity and could be dangerous. CURE Pharmaceutical is working on a way to […]
Intraoral Scanner Can Now Be Used to Produce Panthera Oral Appliances
Panthera Sleep designs, develops, manufactures and markets high-end Mandibular Advancement Devices (MAD) for the treatment of snoring and/or obstructive sleep apnea. The Planmeca Emerald™ intraoral scanner can now be smoothly integrated into sleep practices’ workflows. After scanning the upper and lower arches, first alone and then in occlusion, dentists can instantly export […]
New AADSM Policy Statement Outlines Need for Cross-Collaboration and Educational Requirements in Dental Sleep Medicine
As more physicians and dentists team up to treat obstructive sleep apnea (OSA) patients with oral appliance therapy, there is a need to clarify the best practices for patient-centered care. In response, the American Academy of Dental Sleep Medicine (AADSM) recently published in the Journal of Dental Sleep Medicine its […]
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Sunovion Pharmaceuticals Inc. today announced that the FDA approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution (25 mcg twice daily), also known as SUN-101/eFlow®, for the long-term, maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Sunovion […]
U.S. Army Dental Civilian Corps is Advancing Standards in Dental Sleep Medicine
The U.S. Army Civilian Dental Corps and the U.S. Army Medical Command (MEDCOM), Dental Directorate are highlighting their joint advancements in dental sleep medicine, a field of dental practice that focuses on the use of oral appliance therapy to treat sleep-disordered breathing, including snoring and obstructive sleep apnea, as defined […]
Two Vital Steps to Reboot a Sleep Apnea Dental Program
Recently I received a call from a dentist I met at a national convention a year or so ago. He has been struggling trying to get his team on track delivering sleep apnea care in his dental office. He’s committed to providing care at the very highest level. As it […]











